Prof Eliza Hawkes
Honorary Professorial Fellow
Department of Medicine
325 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.
DOI: 10.1200/JCO-26-009472026
Journal article
Toxicity Under-Reporting in Early-Phase Plasma Cell Dyscrasia Clinical Trial Abstracts.
DOI: 10.1200/OP-25-012442026
Journal article
Significant variations in first-line mantle cell lymphoma care-an Australasian Lymphoma and Related Diseases Registry study.
DOI: 10.1080/10428194.2026.26730992026
Journal article
Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analyses.
DOI: 10.1182/bloodadvances.20260200122026
Journal article
Toxicity outcomes in phase 1 lymphoma trials abstracts are under-reported, with high use of minimizing language
DOI: 10.1002/hem3.703512026
Journal article
Body Mass Index and Clinical Associations in Australasian Lymphoma Patients: A Lymphoma and Related Diseases Registry Study
DOI: 10.1002/jha2.702122026
Journal article
Older patients with lymphoma: navigating a landscape of clinical controversies and barriers to innovation.
DOI: 10.3324/haematol.2025.288700
RECENT SCHOLARLY WORKS
2026
Journal article
FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma
DOI: 10.1200/JCO-25-008922026
Journal article
Tailored approaches in mantle cell lymphoma: refining treatment paradigms with an expert panel opinion
DOI: 10.1080/10428194.2026.26404532026
Journal article
Diagnosis-to-treatment interval is associated with outcomes in follicular lymphoma treated with immunochemotherapy
DOI: 10.1182/blood.2026033090